Graduate Programs in Molecular Biosciences

Faculty & Research

News

Bonnie Firestein Named AIMBE Fellow

Bonnie Firestein was named an American Institute for Medical and Biological Engineering (AIMBE) Fellow. As an AIMBE fellow, she is recognized as one of the top 2% of medical and biological engineers.

Rutgers Board of Governors Approves Asset Purchase Agreement for RUCDR Infinite Biologics

Covid-19 Research and Innovation

Discovery Could Help Slow Down Progression of Parkinson’s Disease

Rutgers collaborates with Scripps Research hoping to develop new drug treatment

Rutgers Researcher Uses Genomics and Gene Editing to Help Save Coral Reefs

A Rutgers researcher who seeks to save dying coral reefs will examine their genetic makeup to try to pinpoint the genes involved in coral bleaching caused by climate change.

Rutgers Scientists Reveal New Evidence of Key Mechanism in Alzheimer’s

A novel study involving human brain cells grown in mice provides insight that could lead to potential therapy

Beneficial Bacteria Can Be Restored to C-Section Babies at Birth

Babies born by cesarean section don’t have the same healthy bacteria as those born vaginally, but a Rutgers-led study for the first time finds that these natural bacteria can be restored.

Rutgers Microbiologists’ Research Subject of Feature-Length Documentary

“The Invisible Extinction” chronicles the pioneering work of globetrotting microbiome researchers Martin Blaser and Maria Gloria Dominguez-Bello

How to Stop the Next Pandemic Before It Starts

Rutgers is joining a nationwide project to develop preemptive treatments for viruses that have the potential to become pandemics.

New AI Method May Boost Crohn’s Disease Insight and Improve Treatment

Rutgers-led study uses artificial intelligence to examine genetic signatures of inflammatory bowel illness

Rutgers University Launches the Nation’s Largest Study of Health Care Workers Exposed to COVID-19

More than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital are participating in a pioneering study

CBD Shows Health Benefits in Estrogen-Deficient Mice that Model Postmenopause

Rutgers study shows cannabidiol may be a possible treatment for postmenopausal women

Rutgers and Tel Aviv University Enter Partnership to Boost Research Collaboration

Rutgers President Jonathan Holloway and Ariel Porat, president of Tel Aviv University, signed a memorandum of understanding that will further the collaboration between the two research universities.

COVID-19 Testing Kits Also Can Measure Oral Microbiome in Saliva

Rutgers study can help lung health in people with COVID-19

Understanding "Chemo Brain" in Children

Understanding ‘Chemo Brain’ in Children: Researchers Secure $4.6 Million NIH Grant to Identify Those at Risk

Bacteria May Travel Thousands of Miles Through the Air Globally

Study could shed light on harmful bacteria that share antibiotic resistance genes

Two Rutgers Professors Elected Senior Members of the National Academy of Inventors

Jeffrey D. Laskin and Thomas Nosker among first to be honored for fostering innovation, mentoring tomorrow's inventors

Technology Developed at Rutgers Sublicensed to Global Biopharmaceutical Company

Base editing technology invented at Rutgers, The State University of New Jersey, and exclusively licensed to Revvity, Inc. subsidiary Horizon Discovery, has been sub-licensed to biopharmaceutical company AstraZeneca to support its creation of cell therapies for the treatment of cancer and immune-mediated diseases.

Antibiotics in Early Life Could Affect Brain Development

Exposure to antibiotics in utero or after birth could lead to brain disorders in later childhood

Rutgers Cancer Institute of New Jersey Research Leader Elected as a Fellow to the American Association for Cancer Research Academy

Dr. Eileen White is one of 25 scientists from around the world to join the 2021 class of fellows

Rutgers Study Identifies Potential Treatment for Inflammatory Bowel Disease

Molecular Machinery That Makes Potent Antibiotic Revealed After Decades of Research

Discovery by Rutgers and other scientists could lead to new antibiotics and anticancer drugs

CBN Assistant Professors Max Tischfield and Rafiq Huda receive Brain and Behavior Research Foundation’s Young Investigator Award

Rafiq Huda and Max Tischfield were both awarded the Young Investigator Awards by the Brain and Behavior Research Foundation. This award supports early-career scientists in neuroscience.

Inexpensive Saline Solution Can Improve Speed, Effectiveness of COVID-19 Testing

A readily accessible saline solution can safely store coronavirus samples, allowing for more effective testing and long-distance transport to labs, Rutgers researchers find

Rutgers Cancer Institute Researchers Receive $2.3 Million to Combat Common Cancers

Funding supports investigation of cell metabolism and tumor development in common cancers

Newly Renovated Research Tower Unveiled

Rutgers University’s Office for Research Unveils Newly Renovated Research Tower Housing Core Services

Two DLS Professors Named Fellows of the American Association for the Advancement of Science

Seizures During Menstrual Cycle Linked to Drug-Resistant Epilepsy

Study finds surprising connection in some women with genetic generalized epilepsy

Rutgers M.D.-Ph.D. Candidate Wins American Medical Association’s National Research Competition

Rutgers M.D.-Ph.D. Candidate Wins American Medical Association’s National Research Competition

Health Care Workers Most at Risk for COVID-19

A Rutgers study finds nurses have the highest prevalence of infection

Rutgers Commits to Equity in STEMM Disciplines

The STEMM Equity Achievement (SEA) Change initiative supports institutions as they identify and address barriers for those excluded or marginalized in the STEMM fields based on their gender, race, ethnicity, disability or other aspects.

  1. Black, Latinx People Confident in COVID-19 Safety Precautions but Skeptical About Vaccines
  2. International Organization Honors Renowned Rutgers Microbiologist
  3. Researchers Uncover Triple Immunotherapy Combination as Potential Treatment for Pancreatic Cancer
  4. Rutgers Saliva Test Approved One Year Ago

Page 1 of 5

White RU Logo

Rutgers is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to: accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.

Copyright © 2023, Rutgers, The State University of New Jersey, an equal opportunity, affirmative action institution. All rights reserved.